Delivery Order SPE2DB20D9354-SPE2DB25FX7V4

Award Date 6/20/25
Potential Completion Date 6/23/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price contract is for the supply of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $110,900.52, is for the supply of TRIKAFTA 100-50-75 MG/150 MG pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,488.12 contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order worth $18,488.12 with a firm fixed price pricing type, and an ultimate completion date of April 2, 2025. The contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG medication, which is a specialized pharmaceutical product. It is not associated with any set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $74,107.32, is for the supply of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $18,488.12 contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical product, with a completion date of June 9, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,053.68 contract is for the delivery of TRIKAFTA 100-50-75 MG/150 MG prescription medication. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract valued at $18,488.12, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. DMS Pharmaceutical Group Inc. holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,488.12, is for the delivery of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a specialized pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 award is for the delivery of the pharmaceutical product TRIKAFTA 100-50-75 MG/150 MG UU 84S. This is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB25FX7V4
    Delivery Order

This is a $18,488.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S medication.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This positions DMS as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

The contract does not have a set-aside designation, and DMS Pharmaceutical Group has consistently secured federal contracts without specific set-aside requirements, leveraging its status as a woman-owned small business to compete effectively in the federal procurement market.

Generated 9/19/25, 10:49 AM